The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Watch how NY will begin to look closer at the reason behind the latest research’s author’s enthusiasm for AVA3996 as well , having est. almost $1 bill in peak revenue for AVA6000!! Cannot wait for further est. for the rest of the AVA family!
Why would Avacta have another Investor meet company at the upcoming numbers unless they had something to tell us!!
Hottest biotech IPO this autumn!
Watch the size buyers stepping in and it is only Thursday, been a short week.
Coronavirus testing and monitoring are set to be scaled up for the winter, the UK’s public health agency has said, as pressures on the health service are expected to rise in the coming months.
Scientists warned last month that the UK was nearly “flying blind” when it comes to Covid, because many of the surveillance programmes that were in place at the height of the pandemic have been wound down.
You must understand that this stock is no longer for day trading !
Patience and being able to afford holding on and picking up more stock on quiet days and you will find you will look very clever by the end of September.
The trick is not to sell too early.
Size buyer stepping in.
Lively week ahead, latest company presentation talks of spinning off The diagnostic business, which with the upcoming AVA news flow, will only highlight the real value of the therapeutic business , if an IPO should be on the cards, before we have somebody else knocking on the door.
With new variant gathering pace and what is required, WHO making the right comments and very relevant now Avacta through their latest acquisition have the required volume capicity.
“ COVID-19 is here to stay, and the world will continue to need tools to prevent it, test for it and treat it,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Through C-TAP, WHO and our partners are committed to making those tools accessible to everyone, everywhere.
Further update on the new variant :
A new highly mutated coronavirus variant has been detected in Switzerland and South Africa, prompting scientists to raise alarm bells over a possible explosion of Covid-19 cases.
The Omicron offshoot, called BA.2.86, carries more than 35 mutations in key portions of the virus compared with XBB.1.5 – the dominant variant through most of 2023.
From the US:
The discovery came as new Covid hospitalisations leaped by 21.6 per cent this week, with an estimated 2,000 Americans requiring specialist care per day, according to figures released by the CDC.